A look at the Diabetes Prevention Program at the 10-year mark showed the program brought lasting results.
Welcome to Paper of the Week, which looks back at some of the most important papers over the past 25 years of The American Journal of Managed Care® and why they matter today.
Long-term effectiveness of the Diabetes Prevention Program received attention at this year’s ADA Scientific Sessions, but it’s not the first time the program has received an interim report card.
A 10-year lookback at the program, including its effect on healthcare spending, appeared in The American Journal of Managed Care® in 2013. At that time, the original DPP Research Group found that the relative risk reduction was still 49% among the those in the lifestyle group and 21% in the metformin group compared with placebo. The researchers also found that enrolling in the lifestyle program saved money in the long run.
For the paper, visit ajmc.com.
Managed Care Reflections: A Q&A With A. Mark Fendrick, MD, and Michael E. Chernew, PhD
December 2nd 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The December issue features a conversation with AJMC Co–Editors in Chief A. Mark Fendrick, MD, director of the Center for Value-Based Insurance Design and a professor at the University of Michigan in Ann Arbor; and Michael E. Chernew, PhD, the Leonard D. Schaeffer Professor of Health Care Policy and the director of the Healthcare Markets and Regulation Lab at Harvard Medical School in Boston, Massachusetts.
Read More